Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Foghorn Therapeutics Inc. (FHTX) had Free Cash Flow per Share of $-1.01 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$8.15M |
|
$-15.85M |
|
-- |
|
$8.15M |
|
$26.65M |
|
$-18.50M |
|
$2.65M |
|
$-15.85M |
|
$-15.85M |
|
$-15.85M |
|
$-15.85M |
|
$-15.85M |
|
$-15.85M |
|
$-18.50M |
|
$-18.00M |
|
63.03M |
|
63.03M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$184.12M |
|
$8.66M |
|
$20.84M |
|
$204.96M |
|
$85.09M |
|
-- |
|
$209.53M |
|
$294.62M |
|
$-89.66M |
|
$-89.66M |
|
$-89.66M |
|
56.54M |
|
| Cash Flow Statement Financials | |
$-63.83M |
|
$98.81M |
|
$0.44M |
|
$57.16M |
|
$92.58M |
|
$35.42M |
|
$8.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-226.92% |
|
-226.92% |
|
-- |
|
-194.39% |
|
-194.39% |
|
$-63.88M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
-- |
|
-- |
|
17.68% |
|
17.68% |
|
-7.73% |
|
17.68% |
|
$-1.59 |
|
|
Free Cash Flow per Share |
$-1.01 |
$-1.01 |
|